MRNA

2024Q3BMO

Moderna Inc primary · HEALTHCARE · BIOTECHNOLOGY

Report 2024-11-07 · Fiscal end 2024-09-30 · Features as of 2024-11-06

← Earnings history

Pre-Earnings Data

Expectations & setup

Street

Consensus EPS-1.90
Consensus rev—
EPS high—
EPS low—
Dispersion—
Analysts—
EPS rev net 7d—
EPS rev net 30d—
Consensus Δ 7d—
Consensus Δ 30d—

Options

Implied move6.4%
IV front—
P/C full—
P/C front—
Features as of2024-11-06

Run-up

Close—
Ret 5d-5.3%
Ret 10d-3.0%
Ret 20d-12.0%
Ret 30d-18.6%

Post-Earnings Data

Results & reaction

Print

Actual EPS
0.03Beat
Estimated EPS-1.90
Actual revenue
1.9B
Surprise %+101.6%
Beat / missBeat
Beat streak 44
Beat streak 84

Reaction

1-day stock reaction-11.2%
Implied vs actual

Implied 6.4%Actual 9.2%

Gap reaction+9.2%
Day result-3.0%
Next-day upNo
Realized / IV1.45×

Post tape

Post 5d-20.9%
Post 10d-23.9%
Post volume18.2M
Vol ×10d3.49×
Vol ×20d3.73×
Post range11.9%